NeuroPace Inc.: Q3 Earnings Snapshot
Update: 2025-11-04
Description
NeuroPace Incorporated, a California-based medical device company, exceeded Wall Street expectations with a smaller-than-anticipated net loss and stronger-than-forecasted revenue. Despite reporting a $3.5 million loss, or $0.11 per share, the company's performance surpassed analyst predictions. NeuroPace's revenue of $27.4 million, surpassing the average forecast of $24.6 million, indicates robust sales. The company also provided an optimistic outlook for the full year, projecting revenue between $97 million and $98 million.
The Daily News Now! — Every city. Every story. AI-powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
1.0x
